Skip to content

MetLife

US · MET #367 by market cap Listed 2000
95.67 -1.93 -1.98%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
  • Total institutional ownership fell 0.3 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
93.49% -0.31pp
Institutions
1,791 -4
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund66.05%
Private Company17.53%
Public Company3.52%
Hedge Fund2.50%
Government Pension Fund1.96%
Sovereign Wealth Fund1.17%
Individual/Insider0.25%
Insurance Company0.22%
Family Office/Trust0.22%
Other6.57%

Top holders as of 2026-11-05

MetLife Policyholder Trust 16.00% · 100.53M sh
BlackRock 8.27% · 51.94M sh
Vanguard Capital Management, LLC 6.07% · 38.15M sh
Dodge & Cox 5.35% · 33.64M sh
Vanguard Portfolio Management, LLC 4.66% · 29.26M sh
Other 57.38%
State Street Global Advisors 3.99% · 25.10M sh
T. Rowe Price Group, Inc. 3.27% · 20.57M sh
Geode Capital Management, LLC 1.97% · 12.35M sh
Pzena Investment Management, Inc. 1.68% · 10.57M sh
UBS Asset Management 1.36% · 8.54M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 44 buys · 6 sells

NameRoleStake
Michel Khalaf Chief Executive Officer 0.10%
John McCallion Executive VP, CFO & Head of Investment Management 0.04%
Ramy Tadros Regional President of U.S. Business & Head of MetLife Holdings 0.03%
Marlene Debel Executive VP, Chief Risk Officer & Head of Insurance Investments 0.02%
Bill Pappas Executive VP and Head of Global Technology & Operations 0.01%
Carlos Gutierrez Former Independent Director 0.01%
Edward Kelly Former Independent Director 0.01%
Denise Morrison Former Independent Director 0.01%
David Herzog Former Independent Director 0.00%
Diana McKenzie Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-09 Michel Khalaf Chief Executive Officer Derivative Exercise and Sale -187,425 $44.65–102.97
2026-11-09 Michel Khalaf Chief Executive Officer Derivative Exercise and Retained +61,304 $45.50–46.85
2026-09-30 William Kennard Independent Director Other Acquisition +544 $94.35
2026-09-30 Christian Mumenthaler Independent Director Other Acquisition +544 $94.35
2026-09-30 Daniel Glaser Independent Director Other Acquisition +544 $94.35
2026-09-30 Michelle Seitz Independent Director Other Acquisition +544 --
2026-09-30 Carla Harris Independent Director Other Acquisition +544 $94.35
2026-09-30 Robert Glenn Hubbard Independent Chairperson Other Acquisition +941 $94.35
2026-09-30 Diana McKenzie Independent Director Other Acquisition +544 $94.35
2026-09-30 Mark Weinberger Independent Director Other Acquisition +544 --
2026-09-30 Jeh Johnson Independent Director Other Acquisition +544 $94.35
2026-09-30 Laura Hay Independent Director Other Acquisition +544 $94.35
2026-09-07 William Kennard Independent Director Other Acquisition +294 $95.50
2026-09-07 Christian Mumenthaler Independent Director Other Acquisition +21 $95.50
2026-09-07 Daniel Glaser Independent Director Other Acquisition +10 $95.50
2026-09-07 Carla Harris Independent Director Other Acquisition +42 $95.50
2026-09-07 Robert Glenn Hubbard Independent Chairperson Other Acquisition +618 $95.50
2026-09-07 Diana McKenzie Independent Director Other Acquisition +157 $95.50
2026-09-07 Jeh Johnson Independent Director Other Acquisition +59 $95.50
2026-09-07 Ramy Tadros Regional President of U.S. Business & Head of MetLife Holdings Other Acquisition +115 $95.50

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

MetLife discussion 0 comments

Add a comment